Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1431157

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1431157

LAMEA Pancrelipase Market Size, Share & Trends Analysis Report By Age (Adults & Geriatrics, and Children), By Distribution Channel, By Application (Chronic Pancreatitis, Cystic Fibrosis, and Others), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 85 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Pancrelipase Market would witness market growth of 10.6% CAGR during the forecast period (2023-2030).

The versatility of this drug extends beyond its primary applications, finding utility in gastrointestinal disorders characterized by impaired digestive enzyme secretion. The pharmaceutical landscape has witnessed a paradigm shift with the advent of cutting-edge drug delivery systems. Innovations such as enteric-coated formulations and microsphere technologies enhance the bioavailability of this drug, improving its efficacy and patient compliance. The age of personalized medicine has permeated the market, with tailored treatment regimens based on individual patient profiles.

Moreover, the surge in gastrointestinal disorders has amplified the demand for this drug. As these conditions often coexist with pancreatic insufficiency, the market is witnessing sustained growth. Pediatric formulations of this medicine have gained prominence, addressing the unique needs of children with pancreatic insufficiency. Manufacturers are focusing on developing child-friendly formulations to enhance treatment adherence and outcomes in this vulnerable patient population. Increased awareness of pancreatic insufficiency among healthcare professionals and patients has led to higher diagnosis rates. This and a proactive approach to managing digestive disorders propel the market forward.

As per the Saudi Arabian Monetary Agency, by the end of 2050, 25 percent of Saudi Arabia's total population of 40 million is projected to be 60 or older. Additionally, it is expected that during the same period, the population of individuals aged 80 or older will increase by 1.6 million, or 4% of the overall populace. Aging is associated with a higher incidence of pancreatic disorders, including chronic pancreatitis and other conditions leading to exocrine pancreatic insufficiency (EPI). The prevalence of these disorders in the aging population contributes to the demand for this drug. As a result, these aspects will boost market growth in the coming years.

The Brazil market dominated the LAMEA Pancrelipase Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $46 Million by 2030. The Argentina market is showcasing a CAGR of 11.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.2% during (2023 - 2030).

Based on Age, the market is segmented into Adults & Geriatrics, and Children. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on Application, the market is segmented into Chronic Pancreatitis, Cystic Fibrosis, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Organon & Co.
  • Digestive Care, Inc.
  • AbbVie, Inc.
  • Vivus LLC
  • Laboratorio Opoterapico Argentino S.A.
  • Nestle S.A
  • Scientific Protein Laboratories, LLC (Hepalink)

LAMEA Pancrelipase Market Report Segmentation

By Age

  • Adults & Geriatrics
  • Children

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Application

  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Pancrelipase Market, by Age
    • 1.4.2 LAMEA Pancrelipase Market, by Distribution Channel
    • 1.4.3 LAMEA Pancrelipase Market, by Application
    • 1.4.4 LAMEA Pancrelipase Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Pancrelipase Market by Age

  • 4.1 LAMEA Adults & Geriatrics Market by Country
  • 4.2 LAMEA Children Market by Country

Chapter 5. LAMEA Pancrelipase Market by Distribution Channel

  • 5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
  • 5.2 LAMEA Hospital Pharmacies Market by Country
  • 5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Pancrelipase Market by Application

  • 6.1 LAMEA Chronic Pancreatitis Market by Country
  • 6.2 LAMEA Cystic Fibrosis Market by Country
  • 6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Pancrelipase Market by Country

  • 7.1 Brazil Pancrelipase Market
    • 7.1.1 Brazil Pancrelipase Market by Age
    • 7.1.2 Brazil Pancrelipase Market by Distribution Channel
    • 7.1.3 Brazil Pancrelipase Market by Application
  • 7.2 Argentina Pancrelipase Market
    • 7.2.1 Argentina Pancrelipase Market by Age
    • 7.2.2 Argentina Pancrelipase Market by Distribution Channel
    • 7.2.3 Argentina Pancrelipase Market by Application
  • 7.3 UAE Pancrelipase Market
    • 7.3.1 UAE Pancrelipase Market by Age
    • 7.3.2 UAE Pancrelipase Market by Distribution Channel
    • 7.3.3 UAE Pancrelipase Market by Application
  • 7.4 Saudi Arabia Pancrelipase Market
    • 7.4.1 Saudi Arabia Pancrelipase Market by Age
    • 7.4.2 Saudi Arabia Pancrelipase Market by Distribution Channel
    • 7.4.3 Saudi Arabia Pancrelipase Market by Application
  • 7.5 South Africa Pancrelipase Market
    • 7.5.1 South Africa Pancrelipase Market by Age
    • 7.5.2 South Africa Pancrelipase Market by Distribution Channel
    • 7.5.3 South Africa Pancrelipase Market by Application
  • 7.6 Nigeria Pancrelipase Market
    • 7.6.1 Nigeria Pancrelipase Market by Age
    • 7.6.2 Nigeria Pancrelipase Market by Distribution Channel
    • 7.6.3 Nigeria Pancrelipase Market by Application
  • 7.7 Rest of LAMEA Pancrelipase Market
    • 7.7.1 Rest of LAMEA Pancrelipase Market by Age
    • 7.7.2 Rest of LAMEA Pancrelipase Market by Distribution Channel
    • 7.7.3 Rest of LAMEA Pancrelipase Market by Application

Chapter 8. Company Profiles

  • 8.1 Organon & Co.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
  • 8.2 Digestive Care, Inc.
    • 8.2.1 Company Overview
  • 8.3 Laboratorio Opoterapico Argentino S.A.
    • 8.3.1 Company Overview
  • 8.4 Scientific Protein Laboratories, LLC (Hepalink)
    • 8.4.1 Company Overview
  • 8.5 AbbVie, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 SWOT Analysis
  • 8.6 Vivus LLC
    • 8.6.1 Company Overview
  • 8.7 Nestle S.A
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Adults & Geriatrics Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Adults & Geriatrics Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Children Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Children Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Online Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Chronic Pancreatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Chronic Pancreatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Cystic Fibrosis Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Cystic Fibrosis Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Pancrelipase Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Pancrelipase Market by Country, 2023 - 2030, USD Million
  • TABLE 27 Brazil Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 28 Brazil Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 29 Brazil Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 30 Brazil Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 31 Brazil Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 32 Brazil Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 33 Brazil Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 34 Brazil Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 35 Argentina Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 36 Argentina Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 37 Argentina Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 38 Argentina Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 39 Argentina Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 40 Argentina Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 41 Argentina Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 42 Argentina Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 43 UAE Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 44 UAE Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 45 UAE Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 46 UAE Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 47 UAE Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 48 UAE Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 49 UAE Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 50 UAE Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 51 Saudi Arabia Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 52 Saudi Arabia Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 53 Saudi Arabia Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 54 Saudi Arabia Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 55 Saudi Arabia Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 56 Saudi Arabia Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 57 Saudi Arabia Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 58 Saudi Arabia Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 59 South Africa Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 60 South Africa Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 61 South Africa Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 62 South Africa Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 63 South Africa Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 64 South Africa Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 65 South Africa Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 66 South Africa Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 67 Nigeria Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 68 Nigeria Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 69 Nigeria Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 70 Nigeria Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 71 Nigeria Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 72 Nigeria Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 73 Nigeria Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 74 Nigeria Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 75 Rest of LAMEA Pancrelipase Market, 2019 - 2022, USD Million
  • TABLE 76 Rest of LAMEA Pancrelipase Market, 2023 - 2030, USD Million
  • TABLE 77 Rest of LAMEA Pancrelipase Market by Age, 2019 - 2022, USD Million
  • TABLE 78 Rest of LAMEA Pancrelipase Market by Age, 2023 - 2030, USD Million
  • TABLE 79 Rest of LAMEA Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 80 Rest of LAMEA Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 81 Rest of LAMEA Pancrelipase Market by Application, 2019 - 2022, USD Million
  • TABLE 82 Rest of LAMEA Pancrelipase Market by Application, 2023 - 2030, USD Million
  • TABLE 83 Key Information - Organon & co.
  • TABLE 84 Key Information - Digestive Care, Inc.
  • TABLE 85 Key Information - Laboratorio Opoterapico Argentino S.A.
  • TABLE 86 Key Information - Scientific Protein Laboratories, LLC
  • TABLE 87 Key information - AbbVie, Inc.
  • TABLE 88 Key Information - Vivus LLC
  • TABLE 89 Key Information - Nestle S.A
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!